Search

everythinglearnresearchcommunity

for

Search:↓

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.

The robotic hair restoration device had a high success rate and was faster than manual methods for Korean patients.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

At-home laser and light devices can safely reduce acne and hair growth when used correctly but are less effective than professional treatments.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

Laser and light treatments can effectively remove hair long-term.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Inflammation affects hair loss; anti-inflammatory treatments may help.

Umbilical cord-derived media is safe and effective for hair growth.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Some common medications can harm male fertility, but many effects can be reversed.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Effervescent formulations may improve minoxidil delivery, increasing effectiveness and reducing applications needed.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Scalp microneedling may improve hair density and thickness for various alopecia types.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.